NASDAQ:KARD Kardigan (KARD) Stock Price, News & Analysis $13.73 +0.13 (+0.96%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Kardigan Stock (NASDAQ:KARD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Kardigan alerts:Sign Up Key Stats Today's Range$13.21▼$13.8350-Day Range$12.63▼$22.0152-Week Range$12.23▼$27.00Volume468,443 shsAverage Volume516,854 shsMarket Capitalization$1.28 billionP/E RatioN/ADividend YieldN/APrice Target$39.50Consensus RatingModerate Buy Company Overview Kardigan is a biopharmaceutical company focused on developing medicines for cardiovascular and cardiometabolic diseases. Its work centers on discovering and advancing therapies intended to address significant unmet needs in heart and vascular health. The company’s activities include drug research, preclinical development and clinical evaluation of potential treatments. Publicly available information about Kardigan’s specific product candidates, operating geographies and leadership is limited.AI Generated. May Contain Errors. Read More Kardigan Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreKARD MarketRank™: 3.21836788942 of 5 starsKardigan scored higher than 64% of companies evaluated by MarketBeat, and ranked 360th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingKardigan has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 2 strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialKardigan has a consensus price target of $39.50, representing about 188.7% upside from its current price of $13.68.Amount of Analyst CoverageKardigan has only been the subject of 4 research reports in the past 90 days.Read more about Kardigan's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Kardigan are expected to decrease in the coming year, from ($3.41) to ($3.59) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Kardigan is -4.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kardigan is -4.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.67% of the float of Kardigan has been sold short.Short Interest Ratio / Days to CoverKardigan has a short interest ratio ("days to cover") of 7.62.Change versus previous monthShort interest in Kardigan has recently increased by 19.30%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKardigan does not currently pay a dividend.Dividend GrowthKardigan does not have a long track record of dividend growth. News and Social Media3.9 / 5News Sentiment1.21 News SentimentKardigan has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Kardigan this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for KARD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added Kardigan to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Kardigan insiders have not sold or bought any company stock.Percentage Held by InstitutionsKardigan has minimal institutional ownership at this time.Read more about Kardigan's insider trading history. Receive KARD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kardigan and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KARD Stock News HeadlinesWilliam Blair Initiates Coverage on Kardigan With Outperform RatingOctober 16, 2026 | marketscreener.comMKARD’s Danicamtiv Trial Progress Puts Genetic Heart Failure in Investor FocusOctober 5, 2026 | tipranks.comWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.October 28 at 1:00 AM | Porter & Company (Ad)Kardigan, Inc. Announces Board and Committee Changes, Effective September 29, 2026October 1, 2026 | marketscreener.comMKardigan Announces Appointment of Kristin Reinke to its Board of DirectorsSeptember 30, 2026 | marketscreener.comMKardigan: Funded Precision Cardiology Offers More Than Pipeline DiversificationSeptember 13, 2026 | seekingalpha.comKardigan to Present at Two September Investor ConferencesSeptember 2, 2026 | businesswire.comKardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ RadarSeptember 2, 2026 | tipranks.comSee More Headlines KARD Stock Analysis - Frequently Asked Questions How have KARD shares performed this year? Kardigan's stock was trading at $22.00 on June 18, 2026. Since then, KARD stock has decreased by 37.8% and is now trading at $13.68. How were Kardigan's earnings last quarter? Kardigan, Inc. (NASDAQ:KARD) issued its earnings results on Tuesday, August, 11th. The company reported ($4.61) EPS for the quarter. When did Kardigan IPO? Kardigan (KARD) raised $400 million in an IPO on Thursday, June 18th 2026. The company issued 25,000,000 shares at a price of $16.00 per share. When does the company's lock-up period expire? Kardigan's lock-up period expires on Tuesday, December 15th. Kardigan had issued 25,000,000 shares in its initial public offering on June 18th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period. Who are Kardigan's major shareholders? Kardigan's top institutional investors include China Universal Asset Management Co. Ltd.. Insiders that own company stock include Paul L Berns and Arch Venture Partners Xiii, Ll. View institutional ownership trends. How do I buy shares of Kardigan? Shares of KARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/11/2026Today10/28/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:KARD CIK2123613 Webwww.kardigan.bio Phone415-573-3220FaxN/AEmployees241Year FoundedN/APrice Target and Rating Average Price Target for Kardigan$39.50 High Price Target$46.00 Low Price Target$25.00 Potential Upside/Downside+187.7%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio8.72 Quick Ratio8.72 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares93,504,000Free FloatN/AMarket Cap$1.28 billion OptionableOptionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:KARD) was last updated on 10/28/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredNvidia's $550 Trillion ProblemDo not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...Decentralized Masters | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredWould Anthropic IPO Burst the Bubble?The biggest IPO in history is likely just weeks away… Anthropic, the company behind Claude AI, is rumoured ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kardigan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kardigan With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
